keyword
https://read.qxmd.com/read/38406869/cardiogenic-shock-in-older-adults-a-focus-on-age-associated-risks-and-approach-to-management-a-scientific-statement-from-the-american-heart-association
#1
REVIEW
Vanessa Blumer, Manreet K Kanwar, Christopher F Barnett, Jennifer A Cowger, Abdulla A Damluji, Maryjane Farr, Sarah J Goodlin, Jason N Katz, Colleen K McIlvennan, Shashank S Sinha, Tracy Y Wang
Cardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assessment and management of cardiogenic shock in this high-risk and growing population are lacking...
February 26, 2024: Circulation
https://read.qxmd.com/read/38040992/critical-care-management-of-patients-after-cardiac-arrest-a-scientific-statement-from-the-american-heart-association-and-neurocritical-care-society
#2
JOURNAL ARTICLE
Karen G Hirsch, Benjamin S Abella, Edilberto Amorim, Mary Kay Bader, Jeffrey F Barletta, Katherine Berg, Clifton W Callaway, Hans Friberg, Emily J Gilmore, David M Greer, Karl B Kern, Sarah Livesay, Teresa L May, Robert W Neumar, Jerry P Nolan, Mauro Oddo, Mary Ann Peberdy, Samuel M Poloyac, David Seder, Fabio Silvio Taccone, Anezi Uzendu, Brian Walsh, Janice L Zimmerman, Romergryko G Geocadin
The critical care management of patients after cardiac arrest is burdened by a lack of high-quality clinical studies and the resultant lack of high-certainty evidence. This results in limited practice guideline recommendations, which may lead to uncertainty and variability in management. Critical care management is crucial in patients after cardiac arrest and affects outcome. Although guidelines address some relevant topics (including temperature control and neurological prognostication of comatose survivors, 2 topics for which there are more robust clinical studies), many important subject areas have limited or nonexistent clinical studies, leading to the absence of guidelines or low-certainty evidence...
December 1, 2023: Neurocritical Care
https://read.qxmd.com/read/38014539/critical-care-management-of-patients-after-cardiac-arrest-a-scientific-statement-from-the-american-heart-association-and-neurocritical-care-society
#3
REVIEW
Karen G Hirsch, Benjamin S Abella, Edilberto Amorim, Mary Kay Bader, Jeffrey F Barletta, Katherine Berg, Clifton W Callaway, Hans Friberg, Emily J Gilmore, David M Greer, Karl B Kern, Sarah Livesay, Teresa L May, Robert W Neumar, Jerry P Nolan, Mauro Oddo, Mary Ann Peberdy, Samuel M Poloyac, David Seder, Fabio Silvio Taccone, Anezi Uzendu, Brian Walsh, Janice L Zimmerman, Romergryko G Geocadin
The critical care management of patients after cardiac arrest is burdened by a lack of high-quality clinical studies and the resultant lack of high-certainty evidence. This results in limited practice guideline recommendations, which may lead to uncertainty and variability in management. Critical care management is crucial in patients after cardiac arrest and affects outcome. Although guidelines address some relevant topics (including temperature control and neurological prognostication of comatose survivors, 2 topics for which there are more robust clinical studies), many important subject areas have limited or nonexistent clinical studies, leading to the absence of guidelines or low-certainty evidence...
November 28, 2023: Circulation
https://read.qxmd.com/read/36890844/minoca-mimic-type-2-myocardial-infarction-due-to-severe-aortic-stenosis-complicated-by-cardiogenic-shock
#4
Momin Islam, Hussam Al Hennawi, Mohamad Bakir, Anwar Khedr, Sachin S Goel
Acute myocardial infarction without significant obstructive coronary disease presents a challenging clinical entity that requires timely intervention. The term myocardial infarction with nonobstructive coronary arteries (MINOCA) describes a working diagnosis attributed to varying etiologies in patients with a presumed ischemic cardiac condition. Several overlapping etiologies can be classified as type 2 myocardial infarction (MI). The 2019 AHA statement established diagnostic criteria and clarified the associated confusion, aiding in appropriate diagnosis...
January 30, 2023: Global Cardiology Science & Practice
https://read.qxmd.com/read/36172589/transcatheter-aortic-valve-replacement-in-patients-undergoing-robotic-totally-endoscopic-coronary-artery-bypass-a-case-series
#5
Ankur Srivastava, Jennifer Smazil, Lauren Roark, Hayla A Shah, Husam H Balkhy, Atman P Shah
Transcatheter aortic valve replacement (TAVR) has been utilized to treat patients with symptomatic aortic stenosis (AS). Recent trials suggest comparable efficacy compared to surgical aortic valve replacement (SAVR). Robotic off-pump totally endoscopic coronary artery bypass graft surgery (TECAB) had been shown to be a minimally invasive revascularization strategy with clinical results comparable to traditional coronary artery bypass graft surgery (CABG). Traditionally, pre-surgical coronary evaluation is considered necessary to optimize coronary revascularization at the time of AVR...
2022: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/35862152/escalating-and-de-escalating-temporary-mechanical-circulatory-support-in-cardiogenic-shock-a-scientific-statement-from-the-american-heart-association
#6
REVIEW
Bram J Geller, Shashank S Sinha, Navin K Kapur, Marie Bakitas, Leora B Balsam, Joanna Chikwe, Deborah G Klein, Ajar Kochar, Sofia C Masri, Daniel B Sims, Graham C Wong, Jason N Katz, Sean van Diepen
The use of temporary mechanical circulatory support in cardiogenic shock has increased dramatically despite a lack of randomized controlled trials or evidence guiding clinical decision-making. Recommendations from professional societies on temporary mechanical circulatory support escalation and de-escalation are limited. This scientific statement provides pragmatic suggestions on temporary mechanical circulatory support device selection, escalation, and weaning strategies in patients with common cardiogenic shock causes such as acute decompensated heart failure and acute myocardial infarction...
August 9, 2022: Circulation
https://read.qxmd.com/read/35753858/2022-aha-acc-key-data-elements-and-definitions-for-cardiovascular-and-noncardiovascular-complications-of-covid-19-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-data-standards
#7
Biykem Bozkurt, Sandeep R Das, Daniel Addison, Aakriti Gupta, Hani Jneid, Sadiya S Khan, George Augustine Koromia, Prathit A Kulkarni, Kathleen LaPoint, Eldrin F Lewis, Erin D Michos, Pamela N Peterson, Mohit K Turagam, Tracy Y Wang, Clyde W Yancy
No abstract text is available yet for this article.
July 26, 2022: Journal of the American College of Cardiology
https://read.qxmd.com/read/35737748/2022-aha-acc-key-data-elements-and-definitions-for-cardiovascular-and-noncardiovascular-complications-of-covid-19-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-data-standards
#8
REVIEW
Biykem Bozkurt, Sandeep R Das, Daniel Addison, Aakriti Gupta, Hani Jneid, Sadiya S Khan, George Augustine Koromia, Prathit A Kulkarni, Kathleen LaPoint, Eldrin F Lewis, Erin D Michos, Pamela N Peterson, Mohit K Turagam, Tracy Y Wang, Clyde W Yancy
No abstract text is available yet for this article.
July 2022: Circulation. Cardiovascular Quality and Outcomes
https://read.qxmd.com/read/35465083/procedural-safety-and-long-term-clinical-outcomes-in-patients-receiving-ultra-long-everolimus-eluting-stent-a-single-center-real-world-experience
#9
JOURNAL ARTICLE
Nagendra Boopathy Senguttuvan, Rahul Kongara, Shanmugasundram Sadhanandham, Nishok Victory Srinivasan, Santhosh Kumar Periyasamy, Balakrishnan Vinod Kumar, Ravi Shankar P, Meena Iyer, Mahalakshmi Ramadoss, Vinodhini Subramanian, Jayanthy Venkata Balasubramaniyan, Preetam Krishnamurthy, Sankaran Ramesh, Panchanatham Manokar, Thoddi Ramamurthy Muralidharan, Jayanthi Sathyanarayana Murthy, Sadagopan Thanikachalam
Background: Diffuse long coronary lesions are difficult to treat percutaneously. The aim of the present study was to assess the procedural safety and long-term efficacy of the ultra-long (48-mm) drug-eluting stent Xience Xpedition. Methods: This was an investigator-initiated, observational, all-comers study. A total of 92 patients with 93 lesions were enrolled in the study from October 2016 to October 2020. The primary outcome of the study was major adverse cardiac events (MACEs)...
April 2022: Cardiology Research
https://read.qxmd.com/read/35379504/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-executive-summary-a-report-of-the-american-college-of-cardiology-american-heart-association-joint-committee-on-clinical-practice-guidelines
#10
JOURNAL ARTICLE
Paul A Heidenreich, Biykem Bozkurt, David Aguilar, Larry A Allen, Joni J Byun, Monica M Colvin, Anita Deswal, Mark H Drazner, Shannon M Dunlay, Linda R Evers, James C Fang, Savitri E Fedson, Gregg C Fonarow, Salim S Hayek, Adrian F Hernandez, Prateeti Khazanie, Michelle M Kittleson, Christopher S Lee, Mark S Link, Carmelo A Milano, Lorraine C Nnacheta, Alexander T Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R Vest, Clyde W Yancy
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. METHODS: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases...
May 3, 2022: Journal of the American College of Cardiology
https://read.qxmd.com/read/35379503/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-a-report-of-the-american-college-of-cardiology-american-heart-association-joint-committee-on-clinical-practice-guidelines
#11
JOURNAL ARTICLE
Paul A Heidenreich, Biykem Bozkurt, David Aguilar, Larry A Allen, Joni J Byun, Monica M Colvin, Anita Deswal, Mark H Drazner, Shannon M Dunlay, Linda R Evers, James C Fang, Savitri E Fedson, Gregg C Fonarow, Salim S Hayek, Adrian F Hernandez, Prateeti Khazanie, Michelle M Kittleson, Christopher S Lee, Mark S Link, Carmelo A Milano, Lorraine C Nnacheta, Alexander T Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R Vest, Clyde W Yancy
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. METHODS: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases...
May 3, 2022: Journal of the American College of Cardiology
https://read.qxmd.com/read/35378259/2022-american-college-of-cardiology-american-heart-association-heart-failure-society-of-america-guideline-for-the-management-of-heart-failure-executive-summary
#12
JOURNAL ARTICLE
Paul A Heidenreich, Biykem Bozkurt, David Aguilar, Larry A Allen, Joni-J Byun, Monica M Colvin, Anita Deswal, Mark H Drazner, Shannon M Dunlay, Linda R Evers, James C Fang, Savitri E Fedson, Gregg C Fonarow, Salim S Hayek, Adrian F Hernandez, Prateeti Khazanie, Michelle M Kittleson, Christopher S Lee, Mark S Link, Carmelo A Milano, Lorraine C Nnacheta, Alexander T Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R Vest, Clyde W Yancy
BACKGROUND: The 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America (AHA/ACC/HFSA) Guideline for the Management of Heart Failure replaces the 2013 ACCF/AHA Guideline for the Management of Heart Failure and the 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure. The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose and manage patients with heart failure...
May 2022: Journal of Cardiac Failure
https://read.qxmd.com/read/35378257/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure
#13
JOURNAL ARTICLE
(no author information available yet)
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. METHODS: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases...
May 2022: Journal of Cardiac Failure
https://read.qxmd.com/read/35363500/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-executive-summary-a-report-of-the-american-college-of-cardiology-american-heart-association-joint-committee-on-clinical-practice-guidelines
#14
REVIEW
Paul A Heidenreich, Biykem Bozkurt, David Aguilar, Larry A Allen, Joni J Byun, Monica M Colvin, Anita Deswal, Mark H Drazner, Shannon M Dunlay, Linda R Evers, James C Fang, Savitri E Fedson, Gregg C Fonarow, Salim S Hayek, Adrian F Hernandez, Prateeti Khazanie, Michelle M Kittleson, Christopher S Lee, Mark S Link, Carmelo A Milano, Lorraine C Nnacheta, Alexander T Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R Vest, Clyde W Yancy
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. METHODS: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases...
April 1, 2022: Circulation
https://read.qxmd.com/read/35363499/2022-aha-acc-hfsa-guideline-for-the-management-of-heart-failure-a-report-of-the-american-college-of-cardiology-american-heart-association-joint-committee-on-clinical-practice-guidelines
#15
REVIEW
Paul A Heidenreich, Biykem Bozkurt, David Aguilar, Larry A Allen, Joni J Byun, Monica M Colvin, Anita Deswal, Mark H Drazner, Shannon M Dunlay, Linda R Evers, James C Fang, Savitri E Fedson, Gregg C Fonarow, Salim S Hayek, Adrian F Hernandez, Prateeti Khazanie, Michelle M Kittleson, Christopher S Lee, Mark S Link, Carmelo A Milano, Lorraine C Nnacheta, Alexander T Sandhu, Lynne Warner Stevenson, Orly Vardeny, Amanda R Vest, Clyde W Yancy
AIM: The "2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure" replaces the "2013 ACCF/AHA Guideline for the Management of Heart Failure" and the "2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure." The 2022 guideline is intended to provide patient-centric recommendations for clinicians to prevent, diagnose, and manage patients with heart failure. METHODS: A comprehensive literature search was conducted from May 2020 to December 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (PubMed), EMBASE, the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant databases...
May 3, 2022: Circulation
https://read.qxmd.com/read/35115207/scai-shock-stage-classification-expert-consensus-update-a-review-and-incorporation-of-validation-studies-this-statement-was-endorsed-by-the-american-college-of-cardiology-acc-american-college-of-emergency-physicians-acep-american-heart-association-aha-european
#16
JOURNAL ARTICLE
Srihari S Naidu, David A Baran, Jacob C Jentzer, Steven M Hollenberg, Sean van Diepen, Mir B Basir, Cindy L Grines, Deborah B Diercks, Shelley Hall, Navin K Kapur, William Kent, Sunil V Rao, Marc D Samsky, Holger Thiele, Alexander G Truesdell, Timothy D Henry
No abstract text is available yet for this article.
March 8, 2022: Journal of the American College of Cardiology
https://read.qxmd.com/read/34720602/predictors-of-in-hospital-mortality-in-cardiogenic-shock-patients-on-vasoactive-or-inotropic-support
#17
JOURNAL ARTICLE
Shuktika Nandkeolyar, Tanya Doctorian, Gary Fraser, Rachel Ryu, Colleen Fearon, David Tryon, Whitney Kagabo, Dmitry Abramov, Christopher Hauschild, Liset Stoletniy, Anthony Hilliard, Antoine Sakr
BACKGROUND: Though controversial, the short-duration in-patient use of inotropes in cardiogenic shock (CS) remain an ACC/AHA Class IIa indication, and are frequently used in the initial treatment of CS. We evaluated in-patient mortality and effect on mortality risk of commonly used vasoactive inotropic medications for the medical management of SCAI stage B and C cardiogenic shock patients in a tertiary care cardiac care unit: dobutamine, dopamine, milrinone, and norepinephrine. METHODS: We retrospectively evaluated 342 patients who received dobutamine, milrinone, dopamine, norepinephrine or a combination of these medications for SCAI stage B and C cardiogenic shock...
2021: Clinical Medicine Insights. Cardiology
https://read.qxmd.com/read/34671860/differences-in-the-2020-esc-versus-2015-esc-and-2014-acc-aha-guidelines-on-the-management-of-acute-coronary-syndromes-in-patients-presenting-without-persistent-st-segment-elevation
#18
REVIEW
Mohammad Keykhaei, Haleh Ashraf, Sina Rashedi, Hossein Farrokhpour, Behnam Heidari, Shaghayegh Zokaei, Sayna Bagheri, Roham Foroumadi, Sara Asgarian, Aslan Amirian, Shahrokh Karbalai Saleh, Stefan James
PURPOSE OF REVIEW: We assessed the differences in the 2020 European Society of Cardiology (ESC) versus 2015 ESC and 2014 American College of Cardiology (ACC) guidelines on the management of non-ST-segment elevation acute coronary syndromes (NSTE-ACS). RECENT FINDINGS: The recent publication of the 2020 ESC has provided a comprehensive series of recommendations on diagnosis and management of patients presenting with NSTE-ACS. However, there are discrepancies between the 2020 ESC versus 2015 ESC and 2014 ACC guidelines, creating uncertainty among clinicians in routine practices...
October 21, 2021: Current Atherosclerosis Reports
https://read.qxmd.com/read/34229446/diagnosis-and-management-of-myocarditis-in-children-a-scientific-statement-from-the-american-heart-association
#19
REVIEW
Yuk M Law, Ashwin K Lal, Sharon Chen, Daniela Čiháková, Leslie T Cooper, Shriprasad Deshpande, Justin Godown, Lars Grosse-Wortmann, Joshua D Robinson, Jeffrey A Towbin
Myocarditis remains a clinical challenge in pediatrics. Originally, it was recognized at autopsy before the application of endomyocardial biopsy, which led to a histopathology-based diagnosis such as in the Dallas criteria. Given the invasive and low-sensitivity nature of endomyocardial biopsy, its diagnostic focus shifted to a reliance on clinical suspicion. With the advances of cardiac magnetic resonance, an examination of the whole heart in vivo has gained acceptance in the pursuit of a diagnosis of myocarditis...
August 10, 2021: Circulation
https://read.qxmd.com/read/33849419/effect-of-covid-19-pandemic-on-performance-measures-in-acute-myocardial-infarction
#20
JOURNAL ARTICLE
Miguel Alejandro Rodriguez-Ramos
Objective    To assess performance measures of attention of STEMI in Coronary Intensive Care Unit in General Hospital Camilo Cienfuegos.Methods    Admitted patients with STEMI, from February-April 2020, were compared with patients from similar period from 2015-2019, and patients from January 2019 to January 2020. Primary endpoint were performance measures according to the 2017 AHA / ACC Clinical Performance and Quality Measures for Adults with STEMI document, and secondary endpoint were all-cause in-hospital mortality and major acute coronary events...
March 30, 2021: Kardiologiia
keyword
keyword
159534
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.